Antigen Targeting & Consulting Services
Antigen Targeting & Consulting Service Incorporated (ATCS Inc), a biotech company formed in 2009, is dedicated in providing top-quality custom-based services in analyzing ANTIGENS at protein level, as well as a R&D entity in developing therapeutic candidates based on modern immunology and oriental traditional medicine.
At BeiGene, we are passionate about our people, science, and creating a lasting impact. These priorities are of utmost importance to our organization. We strive to build a global organization recognized for its impact in cancer research and drug development, talented people, and business ethics. We believe in the power of creativity, innovative science, logic-based problem solving, and interdisciplinary teamwork, which are all key fundamentals to successful research and development. Our organization is agile and fosters a flexible, collaborative, and entrepreneurial culture that empowers our passionate employees with the resources needed to fight cancer.
Casebia Therapeutics is a newly formed joint venture between Bayer and CRISPR Therapeutics that will discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, eye diseases/blindness, and heart disease. Casebia has its own scientific leadership and management team; this enables the Company to run as an independent and sustainable organization separate from the investing partners. CRISPR Therapeutics has contributed its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment to bring CRISPR-Cas9 gene editing technology application to patients.
We offer a broad spectrum of services designed to enhance the performance and reliability of your operations. Our solutions impact the entire planning, project execution, and production lifecycle for manufacturing industries. Whether you need the full spectrum of services or a mix customized to your needs, our experienced teams are here to enable you to reach higher standards across your entire process. We enhance the performance of your people, we maximize the reliability of your facility and equipment, we validate your process, we manage your project, and we maintain quality and therefore compliance. In essence, we Create Value for our customers.
Genturi Inc. is a newly formed genomics startup. The company's mission is to fully develop integrated platforms for the rapid delivery of low-cost, high-resolution genomic maps for clinical and non-clinical research and diagnostics. Genturi's platforms will revolutionize the study of all forms of structural variants, providing low-cost and high-speed access to this presently difficult to acquire genomic information. The ease of accessibility to structural will accelerate the corresponding associations with disease states and clinical adoption. With powerful purpose-built platforms, Genturi promises to provide compelling sample-to-answer solutions to researchers and clinicians alike.
Healthcare Royalty Partners
HealthCare Royalty Partners (HCR) is an investment firm that provides structured financing solutions for the life science industry. HCR provides non-dilutive capital in order to invest in commercial or near-commercial stage assets and companies. HCR also purchases royalties from companies, institutions and inventors. HCR has raised approximately $3.4 billion in committed capital and is headquartered in Stamford, CT with offices in Boston, MA and San Francisco, CA. HCR’s team, together with its Strategic Advisory Board, comprises 32 professionals, including 10 individuals with either PhDs, MDs or advanced degrees in life sciences. Since 2002, HCR's senior professionals have completed more than 60 healthcare investments.
INC Research (Nasdaq:INCR) is a leading global contract research organization (“CRO”) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.
Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its client as a true partner in development.
Northeast Scientific Associates (NESA) is a consultative sales group representing premier manufacturers of scientific research equipment. Our professional team assists you with your laboratory, vivarium, and clinical equipment needs. Experienced scientists and engineers facilitate equipment selection, engage in facility layout and design and introduce cutting-edge advancements in biotechnology.